Ketek Is Emerging As Lens For Wider Hill Scrutiny Of Clinical Trial Integrity

The House Energy and Commerce Committee's inquiries into Sanofi-Aventis' Ketek could be a jumping-off point for a wide-ranging congressional look into the integrity of clinical trials and oversight of companies involved in those trials